4007787550
|
 |
||||||||||||||
| 貨號 | 品名 | 規(guī)格 | 包裝 | 單價 | 貨期 | 庫存 |
| JD200512093449 | 阿維魯單抗 | -- | 5mg | 50000元 | 咨詢客服 | 3天 |
| JD200512093435 | 阿維魯單抗 | -- | 1mg | 17000元 | 咨詢客服 | 3天 |
| 性狀： | Avelumab 是一個人 IgG1 抗 PD-L1 單克隆抗體，具有潛在的抗體依賴性細(xì)胞介導(dǎo)的細(xì)胞毒性作用。 |
| 質(zhì)量標(biāo)準(zhǔn)： | Description Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity. IC50 & Target PD-1/PD-L1[1] References [1]. Fujii R, et al. Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget. 2016 Jun 7;7(23):33498-511. [2]. Grenga I, et al. A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses. Clin Transl Immunology. 2016 May 20;5(5):e83. [3]. Vandeveer AJ, et al. Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor. Cancer Immunol Res. 2016 May;4(5):452-62. |
| 貯存： | Storage Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
